Annual Drug Patent Expirations for SECUADO
Secuado is a drug marketed by Hisamitsu and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
This drug has thirty-four patent family members in nine countries.
The generic ingredient in SECUADO is asenapine. One supplier is listed for this compound. Additional details are available on the asenapine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com